Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
Authors
Keywords
-
Journal
EYE
Volume 27, Issue 7, Pages 787-794
Publisher
Springer Nature
Online
2013-05-31
DOI
10.1038/eye.2013.107
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- INCIDENCE OF ACUTE ENDOPHTHALMITIS AFTER INTRAVITREAL BEVACIZUMAB INJECTION IN A SINGLE CLINICAL CENTER
- (2013) Khalil Ghasemi Falavarjani et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Avastin Doesn't Blind People, People Blind People
- (2012) Serafin Gonzalez et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of Bevacizumab
- (2012) Roger A. Goldberg et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
- (2012) Jennifer Hu et al. ARCHIVES OF OPHTHALMOLOGY
- Macular ischaemia: a contraindication for anti-VEGF treatment in retinal vascular disease?
- (2012) Kleanthis Manousaridis et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity
- (2012) B J Lee et al. EYE
- Changes in Antibiotic Resistance Patterns of Conjunctival Flora Due to Repeated Use of Topical Antibiotics after Intravitreal Injection
- (2012) Eugene Milder et al. OPHTHALMOLOGY
- Ranibizumab for Diabetic Macular Edema
- (2012) Quan Dong Nguyen et al. OPHTHALMOLOGY
- A Safety Review and Meta-Analyses of Bevacizumab and Ranibizumab: Off-Label versus Goldstandard
- (2012) Christine Schmucker et al. PLoS One
- Systemic and Kidney Toxicity of Intraocular Administration of Vascular Endothelial Growth Factor Inhibitors
- (2011) Gaëlle Pellé et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Emerging Evidence Concerning Systemic Safety of Anti-VEGF Agents – Should Ophthalmologists Be Concerned?
- (2011) Laurence S. Lim et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Bacterial Dispersal Associated With Speech in the Setting of Intravitreous Injections
- (2011) Joanne C. Wen ARCHIVES OF OPHTHALMOLOGY
- Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction
- (2011) Aparna Ramasubramanian et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Prevention of postcataract endophthalmitis
- (2011) Charles Q. Yu et al. CURRENT OPINION IN OPHTHALMOLOGY
- Use of intravitreal triamcinolone and bevacizumab in Coats' disease with central macular edema
- (2011) Michael R. R. Böhm et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Endophthalmitis following intravitreal injections
- (2011) Cristina Irigoyen et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Secondary rhegmatogenous retinal detachment following intravitreal bevacizumab in patients with vitreous hemorrhage or tractional retinal detachment secondary to Eales’ disease
- (2011) Atul Kumar et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma
- (2011) Tomomi Higashide et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
- (2011) Chirag P. Shah et al. OPHTHALMOLOGY
- Incidence of Retinal Pigment Epithelial Tears after Intravitreal Ranibizumab Injection for Neovascular Age-Related Macular Degeneration
- (2011) Emmett T. Cunningham et al. OPHTHALMOLOGY
- Effect on Intraocular Pressure in Patients Receiving Unilateral Intravitreal Anti-Vascular Endothelial Growth Factor Injections
- (2011) Quan V. Hoang et al. OPHTHALMOLOGY
- A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS
- (2011) Margriet I Van der Reis et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- ENDOPHTHALMITIS AFTER INTRAVITREAL ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTAGONISTS
- (2011) Andrew A Moshfeghi et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- META-ANALYSIS OF ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR AGENTS
- (2011) Colin A Mccannel RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease
- (2011) Michael Tolentino SURVEY OF OPHTHALMOLOGY
- Intravitreal Bevacizumab (Avastin) for Diabetic Retinopathy: The 2010 GLADAOF Lecture
- (2011) J. Fernando Arevalo et al. Journal of Ophthalmology
- Role of intravitreal bevacizumab in adult onset Coats’ disease
- (2011) Neha Goel et al. INTERNATIONAL OPHTHALMOLOGY
- Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
- (2010) Carsten H. Meyer et al. ACTA OPHTHALMOLOGICA
- Survey of Intravitreal Injection Techniques Among Retinal Specialists in the United States
- (2010) Amy E. Green-Simms et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review
- (2010) C. Schmucker et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Sustained elevation of intraocular pressure after intravitreal injections of anti-VEGF agents
- (2010) T. J. Good et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A review of clinical trials of anti-VEGF agents for diabetic retinopathy
- (2010) Benjamin P. Nicholson et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage
- (2010) Hossein Nazari et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Hemorrhagic Complications after Intravitreal Injections of Ranibizumab in Patients under Coumarin-Type Anticoagulation
- (2010) V. Loukopoulos et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Retinal-Vein Occlusion
- (2010) Tien Y. Wong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ghost Cell Glaucoma After Intravitreal Bevacizumab for Postoperative Vitreous Hemorrhage Following Vitrectomy for Proliferative Diabetic Retinopathy
- (2010) Laura Liu et al. OPHTHALMIC SURGERY LASERS & IMAGING
- Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion
- (2010) Peter A. Campochiaro et al. OPHTHALMOLOGY
- Effects and Complications of Bevacizumab Use in Patients with Retinopathy of Prematurity: A Multicenter Study in Taiwan
- (2010) Wei-Chi Wu et al. OPHTHALMOLOGY
- CLINICAL CHARACTERISTICS OF ENDOPHTHALMITIS AFTER AN INJECTION OF INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR
- (2010) Daphna Mezad-Koursh et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF HEMORRHAGIC COMPLICATIONS AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) OR RANIBIZUMAB (LUCENTIS) INJECTIONS ON SYSTEMICALLY ANTICOAGULATED PATIENTS
- (2010) John O Mason et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Retinal vascular events after intravitreal bevacizumab
- (2009) Ahmad M. Mansour et al. ACTA OPHTHALMOLOGICA
- Retinal artery occlusion following intravitreal anti-VEGF therapy
- (2009) Therese von Hanno et al. ACTA OPHTHALMOLOGICA
- Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti–Vascular Endothelial Growth Factor Therapies
- (2009) Karl Csaky et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Clinical safety of ranibizumab in age-related macular degeneration
- (2009) Ursula Schmidt-Erfurth Expert Opinion On Drug Safety
- Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy
- (2009) K Ghasemi Falavarjani et al. EYE
- Non-arteritic anterior ischemic optic neuropathy (NA-AION) after intravitreal injection of bevacizumab (Avastin®) for treatment of angoid streaks in pseudoxanthoma elasticum
- (2009) Martin Ganssauge et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Dicephalic parapagus conjoined twins: A rare second trimester sonographic diagnosis
- (2009) Ahmet Mete et al. JOURNAL OF CLINICAL ULTRASOUND
- Short-term Effect of Intravitreal Injection of Ranibizumab (Lucentis) on Intraocular Pressure
- (2009) Maurizio Gismondi et al. JOURNAL OF GLAUCOMA
- Anterior Ischemic Optic Neuropathy After Intravitreal Injection of Bevacizumab
- (2009) Hamid Hosseini et al. JOURNAL OF NEURO-OPHTHALMOLOGY
- Sustained Elevation in Intraocular Pressure Associated with Intravitreal Bevacizumab Injections
- (2009) Malik Y. Kahook et al. OPHTHALMIC SURGERY LASERS & IMAGING
- Large Subretinal Haemorrhage following Change from Intravitreal Bevacizumab to Ranibizumab
- (2009) Dimitrios A. Karagiannis et al. OPHTHALMOLOGICA
- Acute Vision Loss after Intravitreal Injection of Bevacizumab (Avastin) Associated with Ocular Ischemic Syndrome
- (2009) Zei-Lun Huang et al. OPHTHALMOLOGICA
- Intravitreal Ranibizumab May Induce Retinal Arteriolar Vasoconstriction in Patients with Neovascular Age-related Macular Degeneration
- (2009) Domniki N. Papadopoulou et al. OPHTHALMOLOGY
- Microincision Vitrectomy Surgery and Intravitreal Bevacizumab as a Surgical Adjunct to Treat Diabetic Traction Retinal Detachment
- (2009) Yusuke Oshima et al. OPHTHALMOLOGY
- ANTIANGIOGENIC THERAPY WITH INTRAVITREAL BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY
- (2009) HUGO QUIROZ-MERCADO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INFECTIOUS ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION OF ANTIANGIOGENIC AGENTS
- (2009) TERESA DIAGO et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- RETINAL PIGMENT EPITHELIAL TEARS IN RANIBIZUMAB-TREATED EYES
- (2009) BRADLEY T. SMITH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INTRAVITREAL INJECTION OF 2.5 mg VERSUS 1.25 mg BEVACIZUMAB (AVASTIN) FOR TREATMENT OF CNV ASSOCIATED WITH AMD
- (2009) MEHDI MODARRES et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- SAFETY OF REPEAT INTRAVITREAL INJECTIONS OF BEVACIZUMAB VERSUS RANIBIZUMAB
- (2009) IOANNIS D. LADAS et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- BEVACIZUMAB PRETREATMENT IN VITRECTOMY WITH SILICONE OIL FOR SEVERE DIABETIC RETINOPATHY
- (2009) PO-TING YEH et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Endophthalmitis Associated with Intravitreal Anti-Vascular Endothelial Growth Factor Therapy Injections in An Office Setting
- (2008) Suman Pilli et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity
- (2008) Shigeru Honda et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Anti–Vascular Endothelial Growth Factor Pharmacotherapy for Age-Related Macular Degeneration
- (2008) Michael S. Ip et al. OPHTHALMOLOGY
- PREDICTORS OF Anti-VEGF-ASSOCIATED RETINAL PIGMENT EPITHELIAL TEAR USING FA AND OCT ANALYSIS
- (2008) ALLEN CHIANG et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF ACUTE ONSET ENDOPHTHALMITIS FOLLOWING INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION
- (2008) JOHN O. MASON et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- INCIDENCE OF ENDOPHTHALMITIS RELATED TO INTRAVITREAL INJECTION OF BEVACIZUMAB AND RANIBIZUMAB
- (2008) DAVID R. FINTAK et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started